Cite
MLA Citation
Richard Furie et al.. “P130 Treatment of SLE with the immunoproteasome inhibitor KZR-616: results from the first 4 cohorts of the MISSION study, an open-label phase 1b dose escalation trial.” Lupus science & medicine, vol. 7, n.d., p. A93. http://access.bl.uk/ark:/81055/vdc_100137791609.0x000004